Skip to content

Comparison of Platelet Rich Plasma and Steroid Injections for Treating Oral Lichen Planus

COMPARATIVE EVALUATION OF INTRALESIONAL PLATELET-RICH PLASMA VERSUS INTRALESIONAL TRIAMCINOLONE FOR THE MANAGEMENT OF ORAL LICHEN PLANUS: A PROSPECTIVE STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109071
Enrollment
52
Registered
2026-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Intralesional Platelet-Rich Plasma (PRP): Autologous platelet-rich plasma will be prepared from the patient s venous blood using standard centrifugation technique. The prepared PRP will

Sponsors

Dr Bijum Toko
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptomatic cases of oral lichen planus burning sensation and pain. Age range from 18 to 70 years. Clinical and histopathological picture that suggests the diagnosis of oral lichen planus. Patients who give consent for the treatment

Exclusion criteria

Exclusion criteria: Thongprasom sign scoring, score 0 no lesions, normal mucosa. Asymptomatic patients. Systemic disorders hematological diseases, cardiovascular diseases, diabetes mellitus, hypertension. Platelet count less than 150,000 mm3 Hemoglobin less than 11g/dl. Pregnant or active breastfeeding females. Patients who had a lesion(s) with dysplasia. Patients with recent exposure to medications known to cause oral lichenoid reactions. Patients under anticoagulants or immunosuppression drugs

Design outcomes

Primary

MeasureTime frame
Reduction in pain and burning sensation assessed using Visual Analogue Scale at baseline and weekly intervals up to 4 weeksTimepoint: Reduction in pain and burning sensation assessed using Visual Analogue Scale at baseline and weekly intervals up to 4 weeks

Secondary

MeasureTime frame
Comparison of efficacy between the two treatment groupsTimepoint: Change in clinical severity assessed using Thongprasom scoring system up to 12 weeks

Countries

India

Contacts

Public ContactDr Ajay Parihar

Government College of Dentistry, Indore, M.P

ajaycbct@gmail.com09977884488

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026